ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628559 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628559; 2) Community: the network communities that were significantly associated with the response to NSC 628559; 3) Molecule: the relationships between components within communities and NSC 628559; 4) MDR: the compounds that were significantly associated with the NSC 628559.

NSC Compound Enrichment Correlation
NSC 641225 Null 0.0306776553926123 0.18647738
NSC 657676 Null 0.0306776553926123 0.021349562
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0306776553926123 -0.15852406
NSC 674454 (Z)-3-iodo-1,2-diphenyl-2-propen-1-one 0.0306776553926123 0.16465049
NSC 693765 Null 0.0306776553926123 0.1292861
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0306776553926123 0.25592431
NSC 633203 Null 0.0312262198176281 0.073783262
NSC 639186 Raltitrexed 0.0312262198176281 0.057449702
NSC 657305 Null 0.0312262198176281 0.36104561
NSC 659162 1H-Benzimidazole, 5,5'-dithiobis[2-(trifluoromethyl)- (9CI) 0.0312262198176281 -0.047452142
Total:80  Current:53    [First] [Prev] [Next] [Last]